tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AngioDynamics says still expects to be cash flow positive for FY26
PremiumThe FlyAngioDynamics says still expects to be cash flow positive for FY26
3d ago
AngioDynamics reports Q2 adjusted EPS 0c, consensus (10c)
Premium
The Fly
AngioDynamics reports Q2 adjusted EPS 0c, consensus (10c)
3d ago
AngioDynamics backs FY26 adjusted EPS view (33c)-(23c), consensus (33c)
Premium
The Fly
AngioDynamics backs FY26 adjusted EPS view (33c)-(23c), consensus (33c)
3d ago
Buy Rating for AngioDynamics Driven by New Clinical Trial and Product Synergy
PremiumRatingsBuy Rating for AngioDynamics Driven by New Clinical Trial and Product Synergy
25d ago
AngioDynamics Announces Board Election at Annual Meeting
Premium
Company Announcements
AngioDynamics Announces Board Election at Annual Meeting
2M ago
Angiodynamics’ Innovative Study on Colorectal Liver Metastases Treatment: A Potential Game-Changer
Premium
Company Announcements
Angiodynamics’ Innovative Study on Colorectal Liver Metastases Treatment: A Potential Game-Changer
2M ago
AngioDynamics Reports Strong Growth in Earnings Call
PremiumCompany AnnouncementsAngioDynamics Reports Strong Growth in Earnings Call
3M ago
AngioDynamics’ Strong 1Q26 Performance and Promising Outlook Justify Buy Rating
Premium
Ratings
AngioDynamics’ Strong 1Q26 Performance and Promising Outlook Justify Buy Rating
3M ago
AngioDynamics price target raised to $18 from $17 at Canaccord
Premium
The Fly
AngioDynamics price target raised to $18 from $17 at Canaccord
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100